查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1789545

智慧胰岛素笔市场按适应症、性别、分销管道和地区划分

Smart Insulin Pen Market, By Indication, By Connectivity, By Distribution Channel, and by Region
出版日期: | 出版商: Coherent Market Insights | 英文 105 Pages | 商品交期: 2-3个工作天内

价格
简介目录

智慧胰岛素笔市场规模预计在 2025 年达到 5,450 万美元，预计到 2032 年将达到 1.153 亿美元，2025 年至 2032 年的复合年增长率为 11.3%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 5450万美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期：2025-2032年复合年增长率： 11.30% 2032年价值预测 1.153亿美元

智慧胰岛素笔是可重复使用的注射器笔，配有直觉的智慧型手机应用程序，可帮助糖尿病患者更好地管理胰岛素剂量。这些智慧型系统可以计算和追踪剂量，并提供实用的提醒、警报和报告。它们可以作为您现有胰岛素笔的附加组件，也可以作为使用预填充药筒（而非管瓶或一次性胰岛素笔）的可重复使用设备。第一批胰岛素笔于 20 世纪 80 年代末期推出，作为管瓶和注射器的替代品，可以更精确地给药、更好地坚持用药并减少注射部位的疼痛。随着这些设备的发展，它们配备了数位显示器并开始储存最新的胰岛素剂量。最终，数据追踪附件的开发，使抛弃式胰岛素笔能够更好地追踪剂量。随后，血糖感测、持续血糖监测、给药定时、提醒和其他功能也得到了发展。美国食品药物管理局(FDA) 批准的第一款可重复使用的智慧胰岛素笔于 2017 年发布。智能笔的设计易于使用。只需将应用程式下载到您的智慧型手机，并将其与胰岛素笔配对，即可开始使用。该设备透过蓝牙连接将即时数据发送到应用程式。

市场动态

全球糖尿病盛行率的不断上升、主要市场参与者采取的收购併购等成长策略、新型胰岛素产品的推出以及研发活动的不断开展，正在推动全球智慧胰岛素笔市场的成长。例如，2020年8月12日，美国医疗服务公司美敦力宣布计画收购美国医疗医疗设备。 Companion Medical是InPen的製造商，InPen是一款经美国食品药物管理局批准的智慧胰岛素笔系统，并配备整合的糖尿病管理应用程式。

本次调查的主要特点

  • 本报告对全球智慧胰岛素笔市场进行了详细分析，并以 2024 年为基准年，提供了预测期 2025-2032 的市场规模（百万美元）和年复合成长率(CAGR)。
  • 它揭示了不同领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
  • 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球智慧胰岛素笔市场的主要企业。
  • 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球智慧胰岛素笔市场报告涉及该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
  • 相关人员将透过用于分析全球智慧胰岛素笔市场的各种策略矩阵更轻鬆地做出决策。

目录

第一章：调查目标和先决条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章：市场动态、法规与趋势分析

  • 市场动态
    • 驱动程式
    • 抑制因素
    • 市场机会
  • 影响分析
  • 最新产品发布
  • 流行病学
  • 合併、收购和合作
  • 监管情景
  • 主要进展
  • PEST分析

4. 全球智慧胰岛素笔市场（以适应症划分），2020 年至 2032 年

  • 1型糖尿病
  • 2型糖尿病

5. 全球智慧胰岛素笔市场（按连结性别划分），2020 年至 2032 年

  • Bluetooth
  • USB

6. 全球智慧胰岛素笔市场（按分销管道划分），2020-2032 年

  • 诊所及门诊手术中心
  • 电子商务
  • 零售药局

7. 2020-2032 年全球智慧胰岛素笔市场（按地区）

  • 北美洲
      • 美国
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
      • 其他拉丁美洲
  • 欧洲
      • 英国
      • 德国
      • 义大利
      • 法国
      • 西班牙
      • 俄罗斯
      • 其他欧洲国家
  • 亚太地区
      • 中国
      • 印度
      • 日本
      • ASEAN
      • 澳洲
      • 韩国
      • 其他亚太地区
  • 中东
      • GCC
      • 以色列
      • 其他中东地区
  • 非洲
      • 北非
      • 中部非洲
      • 南非

第八章 竞争态势

  • Digital Medics Pty. Ltd.
  • Emperra GmbH E-Health Technologies
  • Novo Nordisk
  • Companion Medical Inc.
  • Jiangsu Deflu Medical Device Co. Ltd.
  • Medtronic PLC
  • Pendiq GmbH
  • Sanofi
  • Berlin Chemie Companion Medical Inc.
  • Bigfoot Biomedical
  • Digital Medics Pty Ltd
  • Eli Lilly and company
  • Ypsomed Holding AG
  • Diabnext Diamesco Co. Ltd.

第九章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI3436

Smart Insulin Pen Market is estimated to be valued at USD 54.5 Mn in 2025 and is expected to reach USD 115.3 Mn by 2032, growing at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 54.5 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.30% 2032 Value Projection: USD 115.3 Mn

A smart insulin pen is a reusable injector pen with an intuitive smartphone app that can help people with diabetes better manage insulin delivery. This smart system calculates and tracks doses and provides helpful reminders, alerts, and reports. They can come in the form of an add-on to current insulin pen or a reusable form which uses prefilled cartridges instead of vials or disposable pens. The first insulin pen devices were introduced in the late 1980s as an alternative to vials and syringes. They allowed for more accurate dosing, better adherence, and less injection site pain. As these devices evolved, they gained digital displays and memory of the most recent insulin doses. Eventually, data tracking attachments were developed to help disposable insulin pens keep better track of doses. Glucose sensing, continuous glucose monitoring, dosage timing, reminders, and other advancements followed. The first U.S. Food and Drug Administration (FDA)-cleared reusable smart insulin pen was launched in 2017. Smart pens are designed to be simple to use. Once the app is downloaded to smartphone and paired it with insulin pen, it is ready to go. The device sends real-time data to the app via Bluetooth connection.

Market Dynamics

Increasing prevalence of diabetes worldwide, adoption of growth strategies such as acquisitions and mergers from key market players, introduction of newer insulin products and research and development activities are driving the growth of global smart insulin pen market. For instance, in August 12, 2020, Medtronics, a U.S.-based medical service company, announced the planned acquisition of Companion Medical, a U.S.-based medical devices manufacturer, who is a manufacturer of InPen- a U.S. Food and Drug Administration cleared smart insulin pen system paired with an integrated diabetes management app.

Key features of the study

  • This report provides an in-depth analysis of the global smart insulin pen market and provides market size (USD Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global smart insulin pen market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Digital Medics Pty. Ltd., Emperra GmbH E-Health Technologies, Novo Nordisk, Companion Medical Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Pendiq GmbH, Sanofi, Berlin Chemie Companion Medical Inc., Bigfoot Biomedical, Digital Medics Pty ltd, Eli Lilly and company, Ypsomed Holding AG, Diabnext Diamesco Co. Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global smart insulin pen market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smart insulin pen market.

Market Segmentation

  • Global Smart Insulin Pen Market, By Indication
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Global Smart Insulin Pen Market, By Connectivity
    • Bluetooth
    • USB
  • Global Smart Insulin Pen Market, By Distribution Channel
    • Clinics and Ambulatory Surgical Centers
    • e-Commerce
    • Retail Pharmacies
  • Global Smart Insulin Pen Market, By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • Digital Medics Pty. Ltd.
    • Emperra GmbH E-Health Technologies
    • Novo Nordisk
    • Companion Medical Inc.
    • Jiangsu Deflu Medical Device Co. Ltd.
    • Medtronic PLC
    • Pendiq GmbH
    • Sanofi
    • Berlin Chemie Companion Medical Inc.
    • Bigfoot Biomedical
    • Digital Medics Pty Ltd.
    • Eli Lilly and company
    • Ypsomed Holding AG
    • Diabnext Diamesco Co. Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Indication
    • Market Snapshot, By Connectivity
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Smart Insulin Pen Market, By Indication, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Type 1 Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • Type 2 Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

5. Global Smart Insulin Pen Market, By Connectivity, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Bluetooth
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • USB
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

6. Global Smart Insulin Pen Market, By Distribution Channel, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Clinics and Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • e-Commerce
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (USD Mn)

7. Global Smart Insulin Pen Market, By Region, 2020 - 2032, (USD Mn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Regions, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country , 2020 - 2032, (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Connectivity , 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020- 2032, (USD Mn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Digital Medics Pty. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Emperra GmbH E-Health Technologies
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novo Nordisk
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Companion Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Jiangsu Deflu Medical Device Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Medtronic PLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Pendiq GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Berlin Chemie Companion Medical Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Bigfoot Biomedical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Digital Medics Pty Ltd
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eli Lilly and company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Ypsomed Holding AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Diabnext Diamesco Co. Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

9. Section

  • Research Methodology
  • About Us